Anemia can be defined as a state of inadequate O2 delivery to tissues due to reduction of the O2 carrying capacity of
blood practically, anemia is diagnosed when there is reduction in the hemoglobin concentration or haematocrit level
below normal values.
Iron deficiency anemia is a major public health problem among women of reproductive age in most of developing
countries approximately 50% of pregnant women and 35% of non pregnant women are anemic.
These nutritional disorders, has profound negative effects on pregnancy outcome, health of mothers and babies.
The objective of this study: Is to evaluate the maternal anemia during pregnancy as a risk factor for fetal growth
restriction.
The study was done this study conducted on 120 pregnant women. Pregnant women with inclusion criteria: Singleton
pregnancy, Gestational age more than 28 week and Hb level less than 10mg/dl. We exclude multiple pregnancy,
Gestational age less than 28 week, Hb level more than 10 mg/dl and other medical disorder with pregnancy.
The results of this study reveal the following: There was significant difference between group 1, 2, 3, 4 as regard to Hb
level, (PCV), (MCV), (MCH), (MCHC), (Ht) and (CBC).
The restriction of fatal growth was significant lower in sever anemic patient rather than mild or moderate anemic patient
In conclusions: The result of this study shows that there was restriction of fatal growth was significantly high in
sever anemic group than mild or moderate group also, incidence of low birth weight and risk of fatal morbidity or
mortality was significantly high in sever anemic group than mild or moderate group.